NO941151L - Lineære adhesjonsinhibitorer - Google Patents
Lineære adhesjonsinhibitorerInfo
- Publication number
- NO941151L NO941151L NO941151A NO941151A NO941151L NO 941151 L NO941151 L NO 941151L NO 941151 A NO941151 A NO 941151A NO 941151 A NO941151 A NO 941151A NO 941151 L NO941151 L NO 941151L
- Authority
- NO
- Norway
- Prior art keywords
- gly
- asn
- lys
- asp
- leu
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- FBKUOPULLUJMOC-UHFFFAOYSA-N 2-[[2-(9h-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 FBKUOPULLUJMOC-UHFFFAOYSA-N 0.000 abstract 1
- SGCGMORCWLEJNZ-UWVGGRQHSA-N His-His Chemical group C([C@H]([NH3+])C(=O)N[C@@H](CC=1NC=NC=1)C([O-])=O)C1=CN=CN1 SGCGMORCWLEJNZ-UWVGGRQHSA-N 0.000 abstract 1
- XWOBNBRUDDUEEY-UWVGGRQHSA-N Leu-His Chemical group CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XWOBNBRUDDUEEY-UWVGGRQHSA-N 0.000 abstract 1
- LCPYQJIKPJDLLB-UWVGGRQHSA-N Leu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(C)C LCPYQJIKPJDLLB-UWVGGRQHSA-N 0.000 abstract 1
- DTERQYGMUDWYAZ-UHFFFAOYSA-N N-acetyl-N-thioacetyl-Lysine Natural products CC(=O)NCCCCC(N)C(O)=O DTERQYGMUDWYAZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 108010091798 leucylleucine Proteins 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4310632A DE4310632A1 (de) | 1993-04-01 | 1993-04-01 | Lineare Adhäsionsinhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO941151D0 NO941151D0 (no) | 1994-03-29 |
| NO941151L true NO941151L (no) | 1994-10-03 |
Family
ID=6484423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941151A NO941151L (no) | 1993-04-01 | 1994-03-29 | Lineære adhesjonsinhibitorer |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0618225A1 (fr) |
| JP (1) | JPH06321988A (fr) |
| CN (1) | CN1099040A (fr) |
| AU (1) | AU5798494A (fr) |
| CA (1) | CA2120302A1 (fr) |
| CZ (1) | CZ70394A3 (fr) |
| DE (1) | DE4310632A1 (fr) |
| HU (1) | HU9400932D0 (fr) |
| NO (1) | NO941151L (fr) |
| SK (1) | SK38494A3 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5770565A (en) * | 1994-04-13 | 1998-06-23 | La Jolla Cancer Research Center | Peptides for reducing or inhibiting bone resorption |
| US5874562A (en) * | 1995-06-07 | 1999-02-23 | Progenitor, Inc. | Nucleic acid encoding developmentally-regulated endothelial cell locus-1 |
| MX9801716A (es) * | 1995-08-30 | 1998-05-31 | Searle & Co | Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina. |
| US6100423A (en) * | 1995-08-30 | 2000-08-08 | G. D. Searle & Co. | Amino benzenepropanoic acid compounds and derivatives thereof |
| IL125756A (en) | 1996-02-15 | 2003-05-29 | Biosense Inc | Catheter for use in surgery |
| US6443974B1 (en) | 1996-07-28 | 2002-09-03 | Biosense, Inc. | Electromagnetic cardiac biostimulation |
| DE69838526T2 (de) | 1998-02-05 | 2008-07-03 | Biosense Webster, Inc., Diamond Bar | Gerät zum Freisetzen eines Medikaments im Herzen |
| WO2000038715A2 (fr) | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | Procede d'utilisation d'un antagoniste de l'integrine et radiotherapie en tant que polytherapie dans le traitement des neoplasies |
| CA2412011A1 (fr) | 2000-06-16 | 2001-12-27 | Hercules Incorporated | Peptides modifies chimiquement, compositions et leur procede de production et d'utilisation |
| GB0323378D0 (en) * | 2003-10-07 | 2003-11-05 | Univ Leicester | Therapeutic agent |
| ATE480561T1 (de) | 2004-10-19 | 2010-09-15 | Lonza Ag | Verfahren zur festphasen-peptidsynthese |
| US20100323950A1 (en) * | 2007-09-11 | 2010-12-23 | Dorian Bevec | Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer |
| EP2187955A2 (fr) * | 2007-09-11 | 2010-05-26 | Mondobiotech Laboratories AG | Utilisation thérapeutique du peptide yglf et combinaison avec kvlpvpq |
| CN106279362B (zh) * | 2015-06-23 | 2019-07-12 | 首都医科大学 | Arg-Leu-Val-Cys-Val，其合成，药理活性和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5049659A (en) * | 1988-02-09 | 1991-09-17 | Dana Farber Cancer Institute | Proteins which induce immunological effector cell activation and chemattraction |
| US5196511A (en) * | 1989-12-01 | 1993-03-23 | The Scripps Research Institute | Peptides and antibodies that inhibit integrin-ligand binding |
-
1993
- 1993-04-01 DE DE4310632A patent/DE4310632A1/de not_active Withdrawn
-
1994
- 1994-03-21 EP EP94104395A patent/EP0618225A1/fr not_active Withdrawn
- 1994-03-23 AU AU57984/94A patent/AU5798494A/en not_active Abandoned
- 1994-03-25 CZ CZ94703A patent/CZ70394A3/cs unknown
- 1994-03-29 NO NO941151A patent/NO941151L/no unknown
- 1994-03-30 CA CA002120302A patent/CA2120302A1/fr not_active Abandoned
- 1994-03-30 CN CN94104073A patent/CN1099040A/zh active Pending
- 1994-03-31 SK SK384-94A patent/SK38494A3/sk unknown
- 1994-03-31 HU HU9400932A patent/HU9400932D0/hu unknown
- 1994-03-31 JP JP6096828A patent/JPH06321988A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU5798494A (en) | 1994-10-06 |
| JPH06321988A (ja) | 1994-11-22 |
| NO941151D0 (no) | 1994-03-29 |
| CZ70394A3 (en) | 1994-12-15 |
| HU9400932D0 (en) | 1994-06-28 |
| EP0618225A1 (fr) | 1994-10-05 |
| CN1099040A (zh) | 1995-02-22 |
| CA2120302A1 (fr) | 1994-10-02 |
| SK38494A3 (en) | 1995-02-08 |
| DE4310632A1 (de) | 1994-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU707094B2 (en) | Analogs of parathyroid hormone | |
| US5955574A (en) | Analogs of parathyroid hormone | |
| US7632811B2 (en) | Analogs of parathyroid hormone | |
| US7410948B2 (en) | Analogs of parathyroid hormone | |
| NO941151L (no) | Lineære adhesjonsinhibitorer | |
| US5969095A (en) | Analogs of parathyroid hormone | |
| AP2000001905A0 (en) | Peptide compositions and formulations and use of same. | |
| AU633913B2 (en) | Novel tnf-inhibit proteins and their preparation | |
| HU211603A9 (en) | Nonapeptide bombesin antagonists | |
| AU630132B2 (en) | Anticoagulant peptides | |
| HUP0003357A2 (hu) | Angiogén hatású ciklusos azapeptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények, eljárás ezek előállítására és alkalmazásuk | |
| ES8701785A1 (es) | Un procedimiento para preparar un peptido ciclico basico conactividad antagonista de v1-vasopresina y oxitocina | |
| EP0384731A2 (fr) | Facteurs de croissance ostéogéniques identifiés à partir de moelle osseuse régénératrice | |
| ES8701784A1 (es) | Un procedimiento para preparar un peptido ciclico con acti- vidad antagonista de vasopresina | |
| AU671850B2 (en) | Peptide lung surfactants and therapeutic combinations | |
| YU48997A (sh) | Novi biološki aktivni proteini, njihove farmaceutske smeše i postupak za njihovo dobijanje | |
| EP0234935A3 (fr) | Composés vasopressine | |
| CN1916025B (zh) | 甲状旁腺素类似物 | |
| CA2102447A1 (fr) | Cyclopeptides | |
| HUP0104071A2 (hu) | Az alfavbéta6-integrint gátló vegyületek | |
| Chen et al. | Synthesis of new substance P analogues releasing histamine from rat peritoneal mast cells | |
| MY125216A (en) | Peptide compositions and formulations and use of same. |